Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
| Autor: | Rogé, Maximilien a, ⁎, Pointreau, Yoann b, Sargos, Paul c, Meyer, Emmanuel d, Schick, Ulrike e, Hasbini, Ali f, Rio, Emmanuel a, Bera, Guillaume g, Ruffier, Amandine b, Quivrin, Magali h, Chasseray, Mathieu e, Latorzeff, Igor i, Martin, Etienne h, Guimas, Valentine a, Pommier, Pascal j, Leroy, Thomas k, Ronchin, Philippe l, Lepinoy, Alexis m, Grand, Audrey n, Cartier, Lysian o, Didas, Ossama p, Denis, Fabrice b, Libois, Vincent a, Blanc-Lapierre, Audrey q, Supiot, Stéphane a |
|---|---|
| Zdroj: | In Clinical and Translational Radiation Oncology May 2023 40 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|